⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13816403 | 0.70 | — | — | |
| SCHEMBL13662468 | 0.63 | S100A4 (0.32) | — | |
| SCHEMBL23758357 | 0.63 | PTGS2 (0.31) | — | |
| SCHEMBL8336874 | 0.63 | NPC1 (0.34) | — | |
| SCHEMBL19403365 | 0.62 | — | — | |
| SCHEMBL910308 | 0.61 | — | — | |
| SCHEMBL17736430 | 0.60 | — | — | |
| SCHEMBL18570404 | 0.59 | CCR1 (0.31) | — | |
| SCHEMBL15980330 | 0.59 | NPC1 (0.31) | — | |
| SCHEMBL19933159 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4104865-A1 | ANTI-EGFR ANTIBODY DRUG CONJUGATES | AbbVie Inc. (US) | 2022-12-21 | — | — | EP | disclosed |